SARMs (Selective Androgen Receptor Modulators) are lab-made chemicals that act a bit like “targeted” steroids for your body. They’re designed to mainly affect muscles (and sometimes bones), helping with growth and strength in those areas.
TL;DR April 2026 Nature paper from 23andMe Research Institute identifies two missense variants — GLP1R rs10305420 (p.Pro7Leu) and GIPR rs1800437 (p.Glu354Gln) — that predict tirzepatide
TL;DR What it is: Tesamorelin (brand name Egrifta) — a 44-amino-acid ghrh analog that stimulates the body’s own growth hormone release in natural pulses, not
A groundbreaking development in the intersection of weight loss and muscle preservation has emerged from recent clinical research, revealing how myostatin inhibition could revolutionize the
A groundbreaking study published in Cureus has sent shockwaves through the bodybuilding and performance enhancement community, revealing previously underestimated liver toxicity risks associated with Selective
The peptide research landscape has reached a significant milestone with the FDA’s recent approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft for lumbar fusion procedures.
A groundbreaking clinical trial has demonstrated that combination glp-1 therapy can effectively reduce body fat while preserving lean muscle mass—a development that could revolutionize body
The peptide research landscape continues to evolve at breakneck speed, with recent developments from Breakthrough T1D highlighting C-peptide as a crucial endpoint in clinical trials.
MK-677 is not natty — it elevates GH and IGF-1 above natural baselines, fails every WADA/NPC Natural drug test, and shows up as institutional cheating in tested sport. Here’s the science.
The biohacking and performance optimization community received unexpected news when reports emerged that Robert F. Kennedy Jr. has proposed reversing the ban on 14 specific
The pharmaceutical landscape continues to evolve with groundbreaking peptide therapies, as the fda recently granted orphan drug designation to a first-in-class peptide treatment for eosinophilic
The global anticancer peptides market is experiencing unprecedented growth, driven by breakthrough clinical trials and promising FDA approvals that could reshape cancer treatment protocols. This
The world of peptide research has reached another significant milestone with NervGen Pharma’s groundbreaking Phase II clinical trial results, demonstrating that targeted peptide therapy can
The peptide revolution that fitness influencer and researcher tony huge has championed for years is finally receiving mainstream scientific scrutiny. A recent Scientific American investigation
The mainstream medical establishment continues to scrutinize the growing peptide injection trend, with University of Virginia experts recently weighing in on safety concerns that have
The FDA’s recent approval of anticancer peptide drug conjugates represents a watershed moment in medical therapeutics, with implications that extend far beyond oncology treatment. For